Connect with us


Drink Makers Seek to Include CBD and Cannabis Beverage Alternatives



Reading Time: 4 minutes

As the cannabis industry continues to develop, savvy consumers and businesses are creating innovative new ways to ingest cannabis. Due to widespread stereotypes, many imagine cannabis users relying on hastily rolled joints. However, as the legal industry continues to accelerate, new products are constantly emerging. For instance, in legal markets such as Colorado or California, extracts and concentrates have become increasingly popular because of their potency and immediate effects. Specifically, Colorado has witnessed its extract and concentrate sales eclipse its flower sales in recent years. And while extracts and concentrates are widely popular, other vendors have incorporated cannabis into edibles and beverages. In particular, edibles are more abundant in regions where recreational cannabis is legal. On the other hand, the cannabis-infused beverage industry is experiencing significant strength because of large beverage corporations entering into the marketspace. Notably, big alcohol has set its sights on the cannabis market because of its declining primary revenue drivers. As a result, many companies are adding cannabis-infused beverages to their product lines in order to combat lower sales numbers that are a result of the declining alcohol consumption levels. However, to note, most companies are predominantly only adding CBD, or cannabidiol, to their beverages because of regulatory restrictions on THC. Moreover, companies are marketing CBD-infused beverages as health and wellness products rather than recreational or relaxation products. And while the infused beverage market is already experiencing a surge in momentum in legal regions, it’s expansion into new territories is expected to spur its growth. According to data compiled by Fior Markets, the global cannabis beverages market is expected to reach USD 4.56 Billion by 2025 while exhibiting a CAGR of 16.8% during the forecast period from 2018 to 2025. BevCanna Enterprises Inc. (CSE: BEV), Anheuser-Busch InBev SA/NV (NYSE: BUD), Molson Coors Brewing Company (NYSE: TAP) (TSX: TPX), HEXO Corp. (NYSE: HEXO) (TSX: HEXO), Harvest Health & Recreation Inc. (OTC: HRVSF) (CSE: HARV)

The therapeutic benefits associated with CBD-infused beverages has already attracted many consumers. According to data by High Yield Insights, approximately 40% of U.S. consumers said they are willing to try CBD, based on unbiased research and physician recommendations. Recent studies have suggested that the properties of CBD can be effective in treating medical conditions associated with cancer, arthritis, migraines, multiple sclerosis, schizophrenia, and epilepsy. However, most consumers are primarily using CBD-infused products for its pain relief, promoting relaxation, or uplifting their mood. While CBD can come in various forms such as flower or extracts, beverages are more popular because they can appeal to more health-conscious consumers. According to Visual Capitalist, infused beverages are much easier to administer and are seen as a healthier way to consume CBD. Furthermore, beverages are more accessible and available and can be easily found in restaurants, supermarkets, convenience stores, and even online e-commerce platforms. While cannabis-infused beverages are most popularly associated with non-alcoholic products, consumers now have a wide-ranging selection to choose from and can find wines, spirits, coffee, tea, kombucha, and sports drinks infused with CBD. However, despite the popularity of the industry, consumers and researchers agree that more transparency is needed for CBD products. And as research progresses, government regulators are expected to establish regulations regarding the addition of CBD into foods and beverages. “The future of the cannabis industry is not just going to be adult and medical use cannabis but the inclusion of CBD in a large array of beverages and foods That trend has already started, and will quickly accelerate with the national legalization of cannabis and the creation of a regulatory structure for inclusion of CBD in edibles. That means that CBD and hemp will figure prominently in the future of both the beverage and the cannabis industry,” according to Joseph V. Micallef, former Chief Executive Officer of Allegro Media Group and keynote speaker for the wine and spirits industry.

BevCanna Enterprises Inc. (OTC: BVNNF) (CSE: BEV) is also listed on the Canadian Securities Exchange under the ticker (CSE: BEV). Earlier last week, the Company announced,

“that its board of directors has appointed Michael Darby as the Chief Financial Officer and Corporate Secretary of the Company, effective July 29, 2019. Mr. Darby succeeds John Campbell, who will continue to hold the role of Chief Strategy Officer of the Company, and who will now focus primarily on merger, acquisition and joint venture opportunities in BevCanna’s two principal markets, Canada and California.

“We’re pleased that Michael has joined the BevCanna team,” said Marcello Leone, CEO of BevCanna. “Michael’s extensive financial management expertise will be an invaluable asset to our team, especially in this period of strategic expansion. His stewardship capabilities across a range of industries, and particularly in the capital markets arena, will be critical as we move forward with our long-term plans.”

“It’s an exciting opportunity that I couldn’t pass up,” noted Mr. Darby. “The cannabis-infused beverage market is on the brink of explosive growth, and BevCanna is at the forefront of the industry. To join a team with the branding, beverage and cannabis expertise that this team jointly holds is very appealing.”

A finance professional with over 25 years of progressively senior financial management experience, Mr. Darby joins BevCanna from Naturo Group Investments Inc. Prior to joining Naturo Group, Mr. Darby served as Chief Financial Officer of Skidmore Group Holdings Inc., a family-owned private equity firm. Previous roles include CFO of TCG International Inc., an international manufacturer, retailer and franchisor of auto & window glass, and Canadian manufacturer & distributor of architectural millwork, and Corporate Controller & Director of Administration of Glentel Inc., a publicly-traded retail telecommunications company.

Mr. Darby is a member of the Chartered Professional Accountants of British Columbia and earned a Bachelor of Commercial Studies degree from the University of Western Ontario.




Global Alliance for Cannabis Commerce Announces Nationwide “GACC Certified™” Testing and Purity Standards Program for Cannabis Products; Responds to Vape-Related Illness Outbreak




The Global Alliance for Cannabis Commerce (GACC), a trade organization representing a major cross-section of the global cannabis industry, today announced the launch of a nationwide, voluntary industry certification standard for safety and purity in cannabis product testing. It is expected by the end of 2020 this program will be available to all state-licensed cannabis operations.  It gives licensed sellers and consumers confidence that the legal products that are approved under this program meet accepted safety and purity standards and are genuine. The standards and testing protocols are expected to meet or exceed the most stringent state standards currently in effect.

“Current laws make it impossible to assure the public that in every one of the 33 states where cannabis has been legalized, that there are uniform accepted standards for safety and purity even though consumers may well use legal product when in different states.  Until federal law is corrected this problem will continue to exist,” said Randal John Meyer, Executive Director at GACC.

“GACC wants to establish a means by which consumers can have confidence in the products they buy and to provide industry the tools to give this assurance. Members will have access to a coordinated national network of ISO certified laboratories that will use scientifically sound and accepted test methods to assure that cannabis meets the most appropriate safety and purity standards,” said GACC President Rezwan Khan. “By the end of next year, cannabis consumers will be able to look at a participating  product anywhere in the United States that it is legally sold, see our blue leaf, and know if it meets the rigorous standard of GACC Certified™ consumer safety testing.”

GACC and each of its member companies believes that absent changes in federal law, it is incumbent on industry to establish consensus industry standards for safety and purity, and to create a serious and effective testing program.

Nominations for membership on the Standards Committee (terms are two years) will be open to the public beginning on Thursday, December 5, 2019, and closing on January 30, 2020.  The Board of GACC will determine the initial composition. Future members will include public nominations and will be determined by the GACCAST Standards Committee and reviewed by the GACC Board of Directors. It is expected that the GACCAST Standards Committee will take approximately nine months to establish the initial standards and protocols so that implementation can begin in 2020.

All current GACC members have pledged to support the development of this standards setting protocol and to adopt and implement it as well when it is effective.  This includes brands such as Raw Garden, DNA Genetics, Crockett Family Farms, Urbn Leaf, La Familia, and Team Elite Genetics, and all derivative cannabis products from DNA Genetics’ and Crockett Family Farms’ genetics.

To accommodate the entire legal cannabis industry’s access to this program, GACC will be creating a new, membership class, the Standard Membership, that will involve minimal costs for participation, and that will provides access to the GACC Certified™ Program. Interested companies may inquire through the GACC website here: GACC is also planning to arrange for testing discounts for members who use the GACC network of laboratories.

GACC President Rezwan Khan added, “Our goal is to ensure this program isn’t cost-prohibitive for any cannabis companies of any size. Cannabis has needed a voluntary unifying force for safety certification for years to increase consumer confidence in its products. Well, here it is—with a number of major cannabis brands already pledging widespread adoption.”

GACC has previously partnered with solo Sciences to ensure that medical patients and adult consumers do not unwittingly purchase counterfeit or illicit vape products. Through the partnership, solo sciences will be offering GACC members a substantial discount on anti-counterfeiting, instant product recall solo*CODE™ technology. “The combination of the voluntary GACC Certified™ consumer safety standard, particularly when combined with members’ access to substantially discounted solo*CODE™ anticounterfeiting technology, allows GACC members to provide their consumers with the confidence they need that anywhere in the United States they legally purchase a participating cannabis product, our blue leaf means it’s safe and genuine,” said GACC Executive Director Randal John Meyer.


SOURCE Global Alliance for Cannabis Commerce

Continue Reading


Dixie Brands’ Wholly-Owned Subsidiary Secures Patent for Scientific Breakthrough in Cannabinoid Delivery




Dixie Brands Inc. (“Dixie” or “the Company”) (CSE: DIXI.U), (OTCQX: DXBRF), (Frankfurt: 0QV), one of the cannabis industry’s leading consumer packaged goods (“CPG”) companies, today announced that the United States Patent and Trademark Office will issue its wholly-owned subsidiary, Aceso Wellness, LLC (“Aceso”), a patent for a unique range of formats providing for the delivery of cannabinoids, along with nutrients, in effervescent powder and/or aqueous liquid forms.

The patent application, entitled ‘Cannabinoid Emulsion Product and Process for Making the Same’, encompasses a broad set of popular formats and formulations that provide for various nutraceutical compositions including cannabinoids, supplements and vitamins. These compositions have been configured for specific uses such as the promotion of the immune system, improved energy levels, joint and bone health, reduced inflammation, and more efficient cellular energy metabolism.

“This patent is the culmination of a 3-year process and demonstrates our commitment to, and investment in, the potential power of the inclusion of cannabinoids to help support healthy lifestyles.” says Jay Denniston C.F.S., Director of Science, Dixie Brands. “It provides proven, efficacious formats for consumers as they continue to explore cannabis as a plant-based, healthy alternative to traditional pharmaceutical products.”

The Company’s patented technology provides an extensive and protected platform to further access the burgeoning US Dietary Supplement market in addition to the rapidly emerging hemp-derived category. The US Dietary Supplement market is expected to grow to nearly US$57 billion by 2024 (Source: Matej Mikulic, Sep 19, 2019) lead by non-pill formats and fueled by increasing consumer awareness of nutrition, a focus on preventative health care and a desire for solutions that are perceived to be more natural.

“This is an incredibly exciting development for Dixie Brands, reflecting the depth of our R&D heritage, established over nearly a decade.” said Chuck Smith, President and CEO, Dixie Brands. “As the FDA provides positive guidance and the category continues to grow, securing patents for our scientific intellectual property not only provides protection for key elements of our portfolio and optimizes shareholder value but also further supports the continued legitimization and normalization of the cannabis industry.”

The patented technology has been commercialized by Aceso’s range of hemp-derived sprays, dissolvable tablets and powder sachets. The effervescent powder lies at the center of the company’s growth strategy in the hemp-derived CBD market due to the existing popularity of that format in the broader health and wellness category. The portfolio currently includes Calm, Soothe and Wellness variants and is available in more than 1,000 brick and mortar stores across the country. The breadth of the forthcoming patent protects the inclusion of cannabinoids in products across a broader range of formats and channels including the regulated cannabis marketplace.


SOURCE Dixie Brands, Inc.

Continue Reading


Avicanna Receives DTC Eligibility for Common Shares on OTCQX




Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of organic and sustainable plant-derived cannabinoid-based products, is pleased to announce that it has obtained eligibility with the Depository Trust Company (“DTC“) for its common shares listed in the United States on the OTCQX® Best Market.

DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through DTC are considered to be “DTC eligible”. DTC eligibility is expected to simplify the process of trading the Company’s common shares on the OTCQX Best Market and enhance liquidity for U.S. Investors.

“With our common stock listed in the U.S. now DTC eligible, a greater number of brokerages and trading platforms will be able to manage trades in our shares. This increased accessibility for investors is expected to improve the liquidity of our shares, which will also help to attract more investors that are following the exciting momentum we are building in our business as we execute on our commercialization strategy,” stated Setu Purohit, President.


SOURCE Avicanna Inc.

Continue Reading

Trending Online

Grassnews is a news publishing website which digests / hand picks the latest news about the cannabis industry, and serves them to you daily.

Contact us:

© 2019 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania